|6 Months Ended|
Mar. 31, 2022
6. Stockholders’ Equity
During the six months ended March 31, 2021, the Company sold common stock of 10.6 million and net proceeds of $10.2 million. shares under an at-the-market sales agreement for gross proceeds of an aggregate of $
Common stock warrants
As of March 31, 2022, the following equity-classified warrants and related terms were outstanding:
Schedule of Warrants Outstanding
During the six months ended March 31, 2021, the Series B warrant holders exercised 2. An additional of Series B warrants were net share settled, resulting in the issuance of shares of common stock. warrants for proceeds of $
During the six months ended March 31, 2021, the Chanticleer warrants to purchase 186,161 shares of common stock with an exercise price of $0.01 per share were net share settled, resulting in the issuance of shares of common stock.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef